Biotech componentsGene Editing

Products 21 to 30 of 33

Non-browning cherries by Intrexon
Biotech components: Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:10 (3 years ago)
Date last modified: 2019/09/12 15:10 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Food
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Non-browning Lettuce by Intrexon
Biotech components: Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:12 (3 years ago)
Date last modified: 2019/09/12 15:12 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Food + Plant
Production process: N/A
Source: N/A
Trading symbol: N/A
Value chain stage: Finished Product
Non-browning Pears by Intrexon
Biotech components: Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:11 (3 years ago)
Date last modified: 2019/09/12 15:11 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Food
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
PRGN-3005: Cancer by Intrexon
Biotech components: Gene Editing + Molecule
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:31 (3 years ago)
Date last modified: 2019/09/12 14:31 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Medical
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Gene Editing + Molecule
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:32 (3 years ago)
Date last modified: 2019/09/12 14:32 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Medical
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Salk Ideal Plants by Salk Institute for Biological Studies
Biotech components: Gene Editing + Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:08 (3 years ago)
Date last modified: 2019/09/12 15:08 (3 years ago)
Known funding amount: N/A
Funding types: Public Funding
Industry: Ecosystem Restoration + Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Plant
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Animal + Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:53 (3 years ago)
Date last modified: 2019/09/12 14:53 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture + Industrial
Market status: Under Development
Organization type(s): Public Company
Product categories: Animal + Food
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Animal + Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:53 (3 years ago)
Date last modified: 2019/09/12 14:53 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Ecosystem Restoration + Food & Agriculture + Health
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Animal
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Self-Limiting Medfly by Intrexon
Biotech components: Animal + Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:53 (3 years ago)
Date last modified: 2019/09/12 14:53 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Public Company
Product categories: Animal
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Animal + Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:53 (3 years ago)
Date last modified: 2019/09/12 14:53 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture + Industrial
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Animal
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product